YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Review of the Retrospective Drug Utilization Review Program from Foreign Countries' Experience

외국의 후향적 DUR 제도 현황과 정책적 함의

  • Kim, Dong-Sook (Department of Research, Health Insurance Review & Assessment Service) ;
  • Kim, Su-Kyeong (Department of Research, Health Insurance Review & Assessment Service) ;
  • Jang, Sun-Mee (Department of Research, Health Insurance Review & Assessment Service)
  • 김동숙 (건강보험심사평가원 심사평가연구실) ;
  • 김수경 (건강보험심사평가원 심사평가연구실) ;
  • 장선미 (건강보험심사평가원 심사평가연구실)
  • Received : 2010.04.22
  • Accepted : 2011.05.19
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study was to review foreign retrospective Drug Utilization Review(DUR), and so to suggest a development plan suitable for use with domestic situation. Literature review of foreign retrospective DUR program and domestic project such as DUR and prescribing analysis project were reviewed. To improve prescribing quality, developed countries such as US, Canada, UK, France, and Australia have implemented various forms of policy. Based on the review of foreign retrospective DUR program, we suggested to apply practical implementation of retrospective DUR program.

Keywords

References

  1. World Health Organization, Rational use of medicines. available at : http://www.who.int/medicines/areas/rational_use/ en/ (2007).
  2. Parish, P. A. : Drug prescribing - the concern of all. R. Soc. Health. J. 4, 213 (1973).
  3. Barber, N. : What constitutes good prescribing? Brit. Med. J. 310, 923 (1995). https://doi.org/10.1136/bmj.310.6984.923
  4. Chapman, S., Durieux, P. and Walley, T. : Chpater 8. Good prescribing practice. In Mossialos, E. Mrazek, M. and Walley, T. : Regulating pharmaceuticals in Europe : striving for efficiency, equity and quality. Open University Press (2004).
  5. Majumdar, S. R., Lipton, H. J. and Soumerai, S. B. : Chapter 28. Evaluation and improving physician prescribing. In Strom BL, Pharmacoepidemiology 4th Ed. University of Pennsylvania (2005).
  6. Institute of Medicine, To err is human: Building a safer health system. National Academy Press (2000).
  7. 김동숙, 장수현, 배승진, 이병란, 최혜린 : 약제심사제도 선진화 방안 연구 - DUR 제도 발전방안을 중심으로. 건강보험심사평가원 (2010).
  8. 김동숙, 변진옥, 김수경, 이병란, 장선미, 박춘선, 강민아 : 약제 급여 적정성 평가 개선방안 연구 - 처방지표를 중심으로. 건강보 험심사평가원 (2009).
  9. Erwin, W. G. : The definition of drug utilization review: statement of issues, Clin Pharmacol Ther. 50(5 Pt 2), 596 (1991). https://doi.org/10.1038/clpt.1991.188
  10. Wertheimer, A. I. : Quality control and drug utilization review. Pharmaceutisch Weekblad Scientific Edition 10, 154 (1988). https://doi.org/10.1007/BF01959424
  11. 배승진, 임민경 : 해외약제 심사제도 연구 - 미국의 처방.조제 전산지원제도를 중심으로. 건강보험심사평가원 (2008).
  12. Omnibus Budget Reconciliation Act '90 (OBRA '90). available at: http://faculty.ksu.edu.sa/hisham/Documents/Pharmacy_ Docs/omnibus.pdf.
  13. Express Script : Drug Trend Report, (2007). available at : http:/ /www.express-scripts.com/industryresearch/industryreports/ drugtrendreport/2007.
  14. Medco. Drug : Trend Report: Predictions, (2008). available at : http://medco.mediaroom.com/file.php/162/2008+DRUG+ TREND+REPORT.pdf.
  15. Towards an Evaluation Framework for Electronic Health Records: An inventory of Electronic Health Records Initiatives Across Canada, Available at : http://www.nlchi.nf.ca/pdf/ Initiatives_mar04.pdf (2004).
  16. TkMC : Program Evaluation of Alberta Management Committee on Drug Utilization (AMCDU)/Alberta Drug Utilization Program (ADUP). Available at : http://www.cadth.ca/media/ compus/cac_review/Jan_2007/Appendix%2037A%20- %20ADUP%20Final%20Evaluation%20Report.pdf (2005).
  17. Alberta Netcare : Using the Pharmaceutical Information Network (PIN) in a Clinical Setting, Available at : http:// www.posp.ab.ca/media/50257/pin%20in%20a%20clinical%20 setting.pdf (2007).
  18. Health Canada : Non-Insured Health Benefits for First Nations and Inuit. Available at http://www.hc-sc.gc.ca/fniah-spnia/nihbssna/ index-eng.php.
  19. Health Canada : Introduction to Non-Insured Health Benefits (NIHB) Drug Benefits List. Available at: http://www.hcsc. gc.ca/fniah-spnia/nihb-ssna/provide-fournir/pharma-prod/ med-list/introduction-eng.php#a8 (2009).
  20. Health Canada : Drug Utilization Evaluation Bulletin, Available at : http://www.hc-sc.gc.ca/fniah-spnia/alt_formats/fnihb-dgspni/ pdf/pubs/nihb-ssna/2008-due-bulletin_eng.pdf (2008).
  21. National Prescribing Center. available at : www.npc.co.uk.
  22. Prescribing Support Unit. available at : http://www.ic.nhs.uk/ psu.
  23. NHS Prescription Service. available at : http://www.nhsbsa. nhs.uk/PrescriptionServices.aspx.
  24. Ashworth, M., Lea, R., Gray, H., Rowlands, G., Gravelle, H. and Majeed, A. : How are primary care organizations using financial incentives to influence prescribing? Journal of Public Health 26, 48 (2004). https://doi.org/10.1093/pubmed/fdh100
  25. Ashworth, M., Lea, R., Gray, H., Gravelle, H. and Majeed, A. : The development of prescribing incentive schemes in primary care: a longitudinal survey. Br. J. Gen. Pract. 53, 468 (2003).
  26. 건강보험심사평가원 : 프랑스 심사기관 방문결과 보고서 (2007. 4).
  27. National Prescribing Service, available at : www.nps.org.au.
  28. Quality Use of Medicine Evaluation Program, available at : http://www.health.gov.au/internet/main/publishing.nsf/Content/ nmp-qumep.htm.
  29. COMPUS(Canadian Optimal Medication Prescribing & Utilization Service) of CADTH(Canadian Agency for Drugs and Technologies in Health), available at : http://www.cadth.ca/ index.php/en/compus.
  30. Sturm, H., Austvoll-Dahlgren, A., Aaserud, M., Oxman, A. D. Ramsay, C., Vernby, A. and Ksters, J. P. : Pharmaceutical policies: effects of financial incentives for prescribers (Review). The Cochrane Library 4, 1 (2009).
  31. Walley, T. and Mossialos, E. : Chapter 10. Financial incentives and prescribing. In Mossialos, E. Mrazek, M. and Walle, T. : Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. Open University Press, England (2004).
  32. NHS : Practice based commissioning: practical implementation (2006).
  33. Center for Medicare & Medicaid. Physician Group Practice (PGP) Demonstration. available at: http://www.cms.gov/ DemoProjectsEvalRpts/MD/itemdetail.asp?filterType= none&filterByDID=0&sortByDID=3&sortOrder=ascending &itemID=CMS1198992&intNumPerPage=10.
  34. IHA(Integrated Healthcare Association). available at: http:// www.iha.org/.
  35. Practice Incentives Program(PIP) available at : http://www. medicareaustralia.gov.au/provider/incentives/pip/paymentformula/ initiative.jsp.
  36. 건강보험심사평가원 : 약제급여 적정성 평가업무 매뉴얼. 건강보험심사평가원 (2007).
  37. Arnold, S. R. and Straus, S. E. : Intervention to improve antibiotic prescribing practices in ambulatory care (Review). The Cochrane Libarry Issue 2 (2009).
  38. Ashworth, M., Golding, S. and Majeed, A. : Prescribing indicators and their use by primary care groups to influence prescribing. Journal Clin. Pharm. & Ther. 27, 197 (2002). https://doi.org/10.1046/j.1365-2710.2002.00405.x
  39. Jones, M. I., Greenfield, S. M., Jowett, S., Nayak, A., Stevenson, F. A. and Bradley, C. P. : Prescribing new drugs: qualitative study of influences on consultants and general practitioners. BMJ 323(7309), 378 (2001). https://doi.org/10.1136/bmj.323.7309.378
  40. Anderson, M. : Is it possible to measure prescribing quality using only prescription data? Basic & Clinical Pharmacology & Toxicology 98, 314 (2006). https://doi.org/10.1111/j.1742-7843.2006.pto_411.x
  41. Hennessy, S., Bilker, W. B., Zhou, L., Weber, A. L., Brensinger, C., Wang, Y. and Strom, B. L. : Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA 290(11), 1494 (2003). https://doi.org/10.1001/jama.290.11.1494